277 related articles for article (PubMed ID: 9632807)
1. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.
Okabe S; Fukuda T; Ishibashi K; Kojima S; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T
Mol Cell Biol; 1998 Jul; 18(7):4235-44. PubMed ID: 9632807
[TBL] [Abstract][Full Text] [Related]
2. Bcl6-dependent transcriptional repression by BAZF.
Takenaga M; Hatano M; Takamori M; Yamashita Y; Okada S; Kuroda Y; Tokuhisa T
Biochem Biophys Res Commun; 2003 Apr; 303(2):600-8. PubMed ID: 12659862
[TBL] [Abstract][Full Text] [Related]
3. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
4. Cloning and characterization of the human BAZF gene, a homologue of the BCL6 oncogene.
Sakashita C; Fukuda T; Okabe S; Kobayashi H; Hirosawa S; Tokuhisa T; Miyasaka N; Miura O; Miki T
Biochem Biophys Res Commun; 2002 Mar; 291(3):567-73. PubMed ID: 11855826
[TBL] [Abstract][Full Text] [Related]
5. A new functional domain of Bcl6 family that recruits histone deacetylases.
Zhang H; Okada S; Hatano M; Okabe S; Tokuhisa T
Biochim Biophys Acta; 2001 Sep; 1540(3):188-200. PubMed ID: 11583814
[TBL] [Abstract][Full Text] [Related]
6. Binding of BAZF and Bc16 to STAT6-binding DNA sequences.
Hartatik T; Okada S; Okabe S; Arima M; Hatano M; Tokuhisa T
Biochem Biophys Res Commun; 2001 Jun; 284(1):26-32. PubMed ID: 11374866
[TBL] [Abstract][Full Text] [Related]
7. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.
Chang CC; Ye BH; Chaganti RS; Dalla-Favera R
Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6947-52. PubMed ID: 8692924
[TBL] [Abstract][Full Text] [Related]
8. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
[TBL] [Abstract][Full Text] [Related]
9. The murine BCL6 gene is induced in activated lymphocytes as an immediate early gene.
Fukuda T; Miki T; Yoshida T; Hatano M; Ohashi K; Hirosawa S; Tokuhisa T
Oncogene; 1995 Oct; 11(8):1657-63. PubMed ID: 7478591
[TBL] [Abstract][Full Text] [Related]
10. The human programmed cell death-2 (PDCD2) gene is a target of BCL6 repression: implications for a role of BCL6 in the down-regulation of apoptosis.
Baron BW; Anastasi J; Thirman MJ; Furukawa Y; Fears S; Kim DC; Simone F; Birkenbach M; Montag A; Sadhu A; Zeleznik-Le N; McKeithan TW
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):2860-5. PubMed ID: 11854457
[TBL] [Abstract][Full Text] [Related]
11. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
12. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
13. Evi9 encodes a novel zinc finger protein that physically interacts with BCL6, a known human B-cell proto-oncogene product.
Nakamura T; Yamazaki Y; Saiki Y; Moriyama M; Largaespada DA; Jenkins NA; Copeland NG
Mol Cell Biol; 2000 May; 20(9):3178-86. PubMed ID: 10757802
[TBL] [Abstract][Full Text] [Related]
14. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers.
Mascle X; Albagli O; Lemercier C
Biochem Biophys Res Commun; 2003 Jan; 300(2):391-6. PubMed ID: 12504096
[TBL] [Abstract][Full Text] [Related]
15. Acetylation inactivates the transcriptional repressor BCL6.
Bereshchenko OR; Gu W; Dalla-Favera R
Nat Genet; 2002 Dec; 32(4):606-13. PubMed ID: 12402037
[TBL] [Abstract][Full Text] [Related]
16. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
Phan RT; Dalla-Favera R
Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of DPZF, a novel human BTB/POZ zinc finger protein sharing homology to BCL-6.
Zhang W; Mi J; Li N; Sui L; Wan T; Zhang J; Chen T; Cao X
Biochem Biophys Res Commun; 2001 Apr; 282(4):1067-73. PubMed ID: 11352661
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression by the proto-oncogene BCL-6.
Seyfert VL; Allman D; He Y; Staudt LM
Oncogene; 1996 Jun; 12(11):2331-42. PubMed ID: 8649773
[TBL] [Abstract][Full Text] [Related]
19. The BTB/POZ domain targets the LAZ3/BCL6 oncoprotein to nuclear dots and mediates homomerisation in vivo.
Dhordain P; Albagli O; Ansieau S; Koken MH; Deweindt C; Quief S; Lantoine D; Leutz A; Kerckaert JP; Leprince D
Oncogene; 1995 Dec; 11(12):2689-97. PubMed ID: 8545127
[TBL] [Abstract][Full Text] [Related]
20. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
